TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
2018 · Nature · 5,347 citations
https://doi.org/10.1038/nature25501
R
Richard Bourgon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
166
Papers
24.6K
Citations
39
h-index
56
i10-index
Richard Bourgon is an academic researcher from Freenome (United States). The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers & Ferroptosis and cancer prognosis. The author has an h-index of 39, co-authored 142 publications.
ORCID: 0000-0002-5890-4374Papers by this author
worksRecurrent R-spondin fusions in colon cancer
2012 · Nature · 967 citations
https://doi.org/10.1038/nature11282
Peripheral T cell expansion predicts tumour infiltration and clinical response
2020 · Nature · 770 citations
https://doi.org/10.1038/s41586-020-2056-8
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
2015 · Cancer Cell · 384 citations
https://doi.org/10.1016/j.ccell.2015.02.001
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
2015 · Journal of Clinical Oncology · 291 citations
https://doi.org/10.1200/jco.2015.61.5005
Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation
2021 · Proceedings of the National Academy of Sciences · 97 citations
https://doi.org/10.1073/pnas.2025840118
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat